We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Identifying Barriers and Strategies to Support Self-efficacy for Medication Adherence With Text Messaging

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02785848
Recruitment Status : Active, not recruiting
First Posted : May 30, 2016
Last Update Posted : August 26, 2022
Sponsor:
Information provided by (Responsible Party):
Robert M Cronin, MD, MS, Vanderbilt University

Tracking Information
First Submitted Date May 25, 2016
First Posted Date May 30, 2016
Last Update Posted Date August 26, 2022
Study Start Date May 2016
Actual Primary Completion Date May 2022   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures
 (submitted: May 27, 2016)		 Number of patients with barriers to medication adherence [ Time Frame: 1 year ]
High cost, forgetting, side effects, access to medications
Original Primary Outcome Measures Same as current
Change History
Current Secondary Outcome Measures
 (submitted: May 27, 2016)		 Number of patients that prefer a tailored text messaging technological solution [ Time Frame: 1 year ]
Original Secondary Outcome Measures Same as current
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title Identifying Barriers and Strategies to Support Self-efficacy for Medication Adherence With Text Messaging
Official Title Identifying Patient-centered Barriers and Preferred Strategies to Support Self-efficacy for Medication Adherence With Two-way Text Messaging
Brief Summary The investigators will explore barriers to improving self-efficacy, or the ability to feel in control of their disease, and medication adherence with text messaging through surveys and interviews with adolescents and adults with SCD cared for at the Vanderbilt Meharry Center of Excellence (VMCE) in Sickle Cell Disease (SCD). The investigators will identify preferences to improve and sustain adherence to daily medication through selection of investigator-proposed or patient-generated text messaging strategies. Finally, the investigators will fill in the literature gaps by describing barriers to self-efficacy and medication adherence among adults with SCD as well as adolescents with SCD who are transitioning to adult care.
Detailed Description Not Provided
Study Type Observational
Study Design Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration Not Provided
Biospecimen Not Provided
Sampling Method Non-Probability Sample
Study Population The investigators will assess barriers to self-efficacy and medication adherence in the adolescents and adults with sickle cell disease (SCD), asthma, or both, who take daily medications such as hydroxyurea, asthma, or both, have access to mobile phones and/or computers and receive care at the VUMC/Matthew Walker clinic.
Condition Sickle Cell Disease
Intervention Other: Interviews and Surveys
The investigators will perform semi-structured interviews and surveys on this cohort
Study Groups/Cohorts Asthma and/or Sickle Cell Anemia
The investigators will examine patients with sickle cell disease, asthma, or both who are aged 12-70 years who take daily medications.
Intervention: Other: Interviews and Surveys
Publications * Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status Active, not recruiting
Actual Enrollment
 (submitted: June 3, 2022)		 70
Original Estimated Enrollment
 (submitted: May 27, 2016)		 50
Estimated Study Completion Date July 2024
Actual Primary Completion Date May 2022   (Final data collection date for primary outcome measure)
Eligibility Criteria

Inclusion Criteria:

  1. Receiving care at the VUMC/Matthew Walker clinic
  2. Diagnosed with SCD, asthma, or both
  3. Currently taking daily medications for SCD, such as hydroxyurea, asthma, or both
  4. Having access to a mobile telephone and/or computer
  5. Age 12-70 years

Exclusion Criteria:

1. Unable to perform interviews or surveys
Sex/Gender
Sexes Eligible for Study: All
Ages 12 Years to 70 Years   (Child, Adult, Older Adult)
Accepts Healthy Volunteers No
Contacts Contact information is only displayed when the study is recruiting subjects
Listed Location Countries United States
Removed Location Countries  
 
Administrative Information
NCT Number NCT02785848
Other Study ID Numbers 160750
Has Data Monitoring Committee No
U.S. FDA-regulated Product Not Provided
IPD Sharing Statement Not Provided
Current Responsible Party Robert M Cronin, MD, MS, Vanderbilt University
Original Responsible Party Robert Cronin, Vanderbilt University, Assistant Professor
Current Study Sponsor Vanderbilt University
Original Study Sponsor Same as current
Collaborators Not Provided
Investigators
Principal Investigator: Robert Cronin, MD, MS Vanderbilt University
PRS Account Vanderbilt University Medical Center
Verification Date August 2022